Dilution of shareholder value from the exercise of stock acquisition rights
First written in FY2016. 4 of 10 entries say "Mitigated", first in FY2017. Latest entry: FY2026.
Striders moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「Tenth Series of Stock Acquisition Rights Common shares 900,000 (Note 1)」
The 900,000 shares underlying the Tenth Series of Stock Acquisition Rights were newly issued, bringing the number of potential shares to 1,300,000 including the 400,000 shares under the Ninth Series. Dilution exposure has increased. - FY2024MitigatedAnnual report
「The decrease in the 8th Series Stock Acquisition Rights during the current consolidated fiscal year was due to the expiration of the exercise period.」
The 435,000 shares underlying the Eighth Series of Stock Acquisition Rights expired upon the end of the exercise period, reducing the number of shares underlying the remaining stock acquisition rights from 835,000 to 400,000. - FY2021MitigatedAnnual report
「The decrease during the current consolidated fiscal year in the Sixth Series of Stock Acquisition Rights resulted from their exercise.」
The 15,000 shares underlying the Sixth Series of Stock Acquisition Rights expired upon exercise, reducing the number of shares underlying the remaining stock acquisition rights from 850,000 to 835,000. Dilution exposure has partially decreased. - FY2021-Q3MaterialisedAnnual report
「After the end of the third quarter consolidated accounting period, the number of issued shares increased by 15,000 upon the exercise of stock acquisition rights.」
After the end of the third quarter accounting period, 15,000 shares were issued upon the exercise of stock acquisition rights, resulting in an actual increase in shares that could lead to dilution. - FY2020MitigatedAnnual report
「The decrease during the current consolidated fiscal year in the Sixth Series of Stock Acquisition Rights resulted from their exercise.」
The number of shares underlying the Sixth Series of Stock Acquisition Rights decreased from 25,000 to 15,000 upon exercise, while the number of shares underlying the remaining stock acquisition rights decreased from 860,000 to 850,000. - FY2020-Q3MaterialisedAnnual report
「1 October 2019–31 December 2019 Change in total issued shares 10,000」
10,000 shares were issued during the third quarter accounting period upon the exercise of stock acquisition rights, bringing the total number of issued shares to 8,897,089. - FY2019WorsenedAnnual report
「Ninth Series of Stock Acquisition Rights (issued 7 December 2018) Common shares 400,000 Total 860,000」
The 400,000 shares underlying the Ninth Series of Stock Acquisition Rights were added, bringing the number of shares underlying the stock acquisition rights remaining at fiscal year-end to 860,000, including those under the Sixth and Eighth Series. Dilution exposure from potential shares increased from 460,000 shares at the end of the previous fiscal year. - FY2017MitigatedAnnual report
「As of the filing date of this annual securities report, the number of shares underlying the stock acquisition rights was 11,700 thousand, equivalent to 13.2% of the 88,730 thousand issued shares. If these stock acquisition rights are exercised, the total number of issued shares will increase, potentially diluting the value per share.」
The number of potential shares decreased from the previously disclosed 17,950 thousand, or 20.2%, to 11,700 thousand, or 13.2%. Meanwhile, 140,000 shares were issued during the fiscal year upon the exercise of stock acquisition rights. - FY2017-Q3MaterialisedAnnual report
「During the third quarter accounting period, shares were issued upon the exercise of stock acquisition rights, bringing the total number of issued shares to 88,820,896 as of the end of the third quarter accounting period.」
90,000 shares were issued during the quarter upon the exercise of stock acquisition rights, bringing the total number of issued shares to 88,820,896. The increase in shares resulting from exercise has occurred in the actual results. - FY2016First statedAnnual report
「As of the filing date of this annual securities report, the number of shares underlying stock acquisition rights was 17,950 thousand, equivalent to 20.2% of the 88,730 thousand issued shares. If these stock acquisition rights are exercised, the number of issued shares will increase and the value per share may be diluted.」
The number of potential shares and its percentage of issued shares are disclosed, with dilution upon exercise identified as a risk.